Top

Published in:

01-04-2018 | Pictorial essay

Hypervascular pancreatic “lesions”: a pattern-based approach to differentiation

Authors: Prasad R. Shankar, Ashish P. Wasnik, Mahmoud M. Al-Hawary, Isaac R. Francis, Ravi K. Kaza

Published in: Abdominal Radiology | Issue 4/2018

Abstract

Hypervascular pancreatic lesions/masses can arise due to a variety of causes, both benign and malignant, leading to a wide differential diagnosis. Accurate differentiation of these lesions into appropriate diagnoses can be challenging; however, this is important for directing clinical management. This manuscript provides a multimodality imaging review of hypervascular pancreatic lesion, with emphasis on an imaging-based algorithmic approach for differentiation of these lesions, which may serve as a decision support tool when encountering these uncommon lesions. Additionally, we stratify these lesions into three categories based on malignant potential, to help guide clinical management.

Stanley JC, Wakefield TW, Graham LM, et al. (1986) Clinical importance and management of splanchnic artery aneurysms. J Vasc Surg 3(5):836–840. doi:10.1016/0741-5214(86)90059-5 CrossRefPubMed

Grotemeyer D, Duran M, Park EJ, et al. (2009) Visceral artery aneurysms–follow-up of 23 patients with 31 aneurysms after surgical or interventional therapy. Langenbeck’s Arch Surg 394(6):1093–1100. doi:10.1007/s00423-009-0482-z CrossRef

Bhosale PR, Menias CO, Balachandran A, et al. (2013) Vascular pancreatic lesions: spectrum of imaging findings of malignant masses and mimics with pathologic correlation. Abdom Imaging 38(4):802–817. doi:10.1007/s00261-012-9954-7 CrossRefPubMed

Vandy FC, Sell KA, Eliason JL, et al. (2017) Pancreaticoduodenal and gastroduodenal artery aneurysms associated with celiac artery occlusive disease. Ann Vasc Surg . doi:10.1016/j.avsg.2016.09.018 PubMed

Corey MR, Ergul EA, Cambria RP, et al. (2016) The presentation and management of aneurysms of the pancreaticoduodenal arcade. J Vasc Surg 64(6):1734–1740. doi:10.1016/j.jvs.2016.05.067 CrossRefPubMed

Thoeni RF (2012) The revised Atlanta classification of acute pancreatitis: its importance for the radiologist and its effect on treatment. Radiology 262(3):751–764. doi:10.1148/radiol.11110947 CrossRefPubMed

Mallick IH, Winslet MC (2004) Vascular complications of pancreatitis. JOP 5(5):328–337PubMed

Hughey M, Taffel M, Zeman RK, Patel S, Hill MC (2017) The diagnostic challenge of the sequelae of acute pancreatitis on CT imaging: a pictorial essay. Abdom Radiol 42(4):1199–1209. doi:10.1007/s00261-016-0986-2 CrossRef

Sfyroeras GS, Antoniou GA, Drakou AA, Karathanos C, Giannoukas AD (2009) Visceral venous aneurysms: clinical presentation, natural history and their management: a systematic review. Eur J Vasc Endovasc Surg 38(4):498–505. doi:10.1016/j.ejvs.2009.05.016 CrossRefPubMed

10.

Kwon OS, Sul YH, Kim JS, Kim JD (2016) Endovascular stent graft for traumatic splenic vein aneurysm via percutaneous transsplenic access. Ann Surg Treat Res 91(1):56–58. doi:10.4174/astr.2016.91.1.56 CrossRefPubMedPubMedCentral

11.

Oberg K (2009) Genetics and molecular pathology of neuroendocrine gastrointestinal and pancreatic tumors (gastroenteropancreatic neuroendocrine tumors). Curr Opin Endocrinol Diabetes Obes 16(1):72–78CrossRefPubMed

12.

Mortele KJ, Mortele B, Silverman SG (2004) CT features of the accessory spleen. AJR 183(6):1653–1657. doi:10.2214/ajr.183.6.01831653 CrossRefPubMed

13.

Halpert B, Gyorkey F (1959) Lesions observed in accessory spleens of 311 patients. Am J Clin Pathol 32(2):165–168CrossRefPubMed

14.

Coquia SF, Kawamoto S, Zaheer A, et al. (2014) Intrapancreatic accessory spleen: possibilities of computed tomography in differentiation from nonfunctioning pancreatic neuroendocrine tumor. J Comput Assist Tomogr 38(6):874–878. doi:10.1097/rct.0000000000000127 CrossRefPubMedPubMedCentral

15.

Kawamoto S, Johnson PT, Hall H, et al. (2012) Intrapancreatic accessory spleen: CT appearance and differential diagnosis. Abdom Imaging 37(5):812–827. doi:10.1007/s00261-011-9830-x CrossRefPubMed

16.

Bhutiani N, Egger ME, Doughtie CA, et al. (2017) Intrapancreatic accessory spleen (IPAS): a single-institution experience and review of the literature. Am J Surg 213(4):816–820. doi:10.1016/j.amjsurg.2016.11.030 CrossRefPubMed

17.

Kim SH, Lee JM, Han JK, et al. (2008) Intrapancreatic accessory spleen: findings on MR Imaging, CT, US and scintigraphy, and the pathologic analysis. Korean J Radiol 9(2):162–174. doi:10.3348/kjr.2008.9.2.162 CrossRefPubMedPubMedCentral

18.

Spencer LA, Spizarny DL, Williams TR (2010) Imaging features of intrapancreatic accessory spleen. Br J Radiol 83(992):668–673. doi:10.1259/bjr/20308976 CrossRefPubMedPubMedCentral

19.

Saunders TA, Miller TR, Khanafshar E (2016) Intrapancreatic accessory spleen: utilization of fine needle aspiration for diagnosis of a potential mimic of a pancreatic neoplasm. J Gastrointest Oncol 7(Suppl 1):S62–S65. doi:10.3978/j.issn.2078-6891.2015.030 PubMedPubMedCentral

20.

Kalb B, Sarmiento JM, Kooby DA, Adsay NV, Martin DR (2009) MR imaging of cystic lesions of the pancreas. Radiographics 29(6):1749–1765. doi:10.1148/rg.296095506 CrossRefPubMed

21.

Kucera JN, Kucera S, Perrin SD, et al. (2012) Cystic lesions of the pancreas: radiologic-endosonographic correlation. Radiographics 32(7):E283–E301. doi:10.1148/rg.327125019 CrossRefPubMed

22.

Sahani DV, Kambadakone A, Macari M, et al. (2013) Diagnosis and management of cystic pancreatic lesions. AJR 200(2):343–354. doi:10.2214/ajr.12.8862 CrossRefPubMed

23.

Khan A, Khosa F, Eisenberg RL (2011) Cystic lesions of the pancreas. Am J Roentgenol 196(6):W668–W677. doi:10.2214/AJR.10.4378 CrossRef

24.

Raman SP, Hruban RH, Cameron JL, et al. (2012) Acinar cell carcinoma of the pancreas: computed tomography features—a study of 15 patients. Abdom Imaging 38:137–143CrossRef

25.

Tatli S, Mortele KJ, Levy AD, et al. (2005) CT and MRI features of pure acinar cell carcinoma of the pancreas in adults. Am J Roentgenol 184(2):511–519. doi:10.2214/ajr.184.2.01840511 CrossRef

26.

Ahmed S, Johnson PT, Hruban R, Fishman EK (2013) Metastatic disease to the pancreas: pathologic spectrum and CT patterns. Abdom Imaging 38(1):144–153. doi:10.1007/s00261-012-9856-8 CrossRefPubMed

27.

Triantopoulou C, Kolliakou E, Karoumpalis I, Yarmenitis S, Dervenis C (2012) Metastatic disease to the pancreas: an imaging challenge. Insights Imaging 3(2):165–172. doi:10.1007/s13244-011-0144-x CrossRefPubMed

28.

Ballarin R, Spaggiari M, Cautero N, et al. (2011) Pancreatic metastases from renal cell carcinoma: the state of the art. World J Gastroenterol 17(43):4747–4756. doi:10.3748/wjg.v17.i43.4747 CrossRefPubMedPubMedCentral

29.

Sweeney AD, Wu MF, Hilsenbeck SG, Brunicardi FC, Fisher WE (2009) Value of pancreatic resection for cancer metastatic to the pancreas. J Surg Res 156(2):189–198. doi:10.1016/j.jss.2009.01.017 CrossRefPubMed

30.

Klein KA, Stephens DH, Welch TJ (1998) CT characteristics of metastatic disease of the pancreas. Radiographics 18(2):369–378. doi:10.1148/radiographics.18.2.9536484 CrossRefPubMed

31.

Nihei K, Sakamoto K, Suzuki S, Mishina T, Otaki M (2016) A case of pancreatic metastasis of renal cell carcinoma. Gan Kagaku Ryoho Cancer Chemother 43(12):2274–2276

32.

Sohn TA, Yeo CJ, Cameron JL, Nakeeb A, Lillemoe KD (2001) Renal cell carcinoma metastatic to the pancreas: results of surgical management. J Gastrointest Surg 5(4):346–351. doi:10.1016/S1091-255X(01)80060-3 CrossRefPubMed

33.

Ro C, Chai W, Yu VE, Yu R (2013) Pancreatic neuroendocrine tumors: biology, diagnosis, and treatment. Chin J Cancer 32(6):312–324. doi:10.5732/cjc.012.10295 CrossRefPubMedPubMedCentral

34.

McKenna LR, Edil BH (2014) Update on pancreatic neuroendocrine tumors. Gland Surgery 3(4):258–275. doi:10.3978/j.issn.2227-684X.2014.06.03 PubMedPubMedCentral

35.

Raman SP, Hruban RH, Cameron JL, Wolfgang CL, Fishman EK (2012) Pancreatic imaging mimics: part 2, pancreatic neuroendocrine tumors and their mimics. Am J Roentgenol 199(2):309–318. doi:10.2214/AJR.12.8627 CrossRef

36.

Tamm EP, Bhosale P, Lee JH, Rohren E (2016) State-of-the-art imaging of pancreatic neuroendocrine tumors. Surg Oncol Clin N Am 25(2):375–400. doi:10.1016/j.soc.2015.11.007 CrossRefPubMedPubMedCentral

37.

Kalra MK, Maher MM, Mueller PR, Saini S (2003) State-of-the-art imaging of pancreatic neoplasms. Br J Radiol 76(912):857–865. doi:10.1259/bjr/16642775 CrossRefPubMed

38.

Cho JH, Ryu JK, Song SY, et al. (2016) Prognostic validity of the American Joint Committee on Cancer and the European Neuroendocrine Tumors Staging classifications for pancreatic neuroendocrine tumors: a retrospective nationwide multicenter study in South Korea. Pancreas 45(7):941–946. doi:10.1097/mpa.0000000000000586 CrossRefPubMed

39.

Intenzo CM, Jabbour S, Lin HC, et al. (2007) Scintigraphic imaging of body neuroendocrine tumors. Radiographics 27(5):1355–1369. doi:10.1148/rg.275065729 CrossRefPubMed

40.

Lewis RB, Lattin GE, Paal E (2010) Pancreatic endocrine tumors: radiologic-clinicopathologic correlation. Radiographics 30(6):1445–1464. doi:10.1148/rg.306105523 CrossRefPubMed

41.

Fidler JL, Fletcher JG, Reading CC (2003) Preoperative detection of pancreatic insulinomas on multiphasic helical CT. AJR 181:775CrossRefPubMed

42.

King AD, Ko GT, Yeung VT, et al. (1998) Dual phase spiral CT in the detection of small insulinomas of the pancreas. Br J Radiol 71(841):20–23. doi:10.1259/bjr.71.841.9534694 CrossRefPubMed

43.

Sahani DV, Bonaffini PA, Fernández-Del Castillo C, Blake MA (2013) Gastroenteropancreatic neuroendocrine tumors: role of imaging in diagnosis and management. Radiology 266(1):38–61. doi:10.1148/radiol.12112512 CrossRefPubMed

44.

Fidler JL, Fletcher JG, Reading CC, et al. (2003) Preoperative detection of pancreatic insulinomas on multiphasic helical CT. Am J Roentgenol 181(3):775–780. doi:10.2214/ajr.181.3.1810775 CrossRef

45.

Mojtahedi A, Thamake S, Tworowska I, Ranganathan D, Delpassand ES (2014) The value of (68)Ga-DOTATATE PET/CT in diagnosis and management of neuroendocrine tumors compared to current FDA approved imaging modalities: a review of literature. Am J Nucl Med Mol Imaging 4(5):426–434PubMedPubMedCentral

46.

Hofman MS, Lau WFE, Hicks RJ (2015) Somatostatin receptor imaging with 68 Ga DOTATATE PET/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation. Radiographics 35(2):500–516. doi:10.1148/rg.352140164 CrossRefPubMed

47.

Geijer H, Breimer LH (2013) Somatostatin receptor PET/CT in neuroendocrine tumours: update on systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 40(11):1770–1780. doi:10.1007/s00259-013-2482-z CrossRefPubMed

48.

Zhu L, Xue H, Sun Z, et al. (2017) Prospective comparison of biphasic contrast-enhanced CT, volume perfusion CT, and 3 Tesla MRI with diffusion-weighted imaging for insulinoma detection. J Magn Reson Imaging . doi:10.1002/jmri.25709 PubMedCentral

49.

Kittah NE, Vella A (2017) Management of Endocrine Disease: pathogenesis and management of hypoglycemia. Eur J Endocrinol . doi:10.1530/eje-16-1062 PubMed

50.

Ellison EC (2008) Zollinger-Ellison syndrome: a personal perspective. Am Surg 74(7):563–571PubMed

51.

Zollinger RM, Ellison EH (1955) Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. Ann Surg 142(4):709–723CrossRefPubMedPubMedCentral

Title: Hypervascular pancreatic “lesions”: a pattern-based approach to differentiation
Authors: Prasad R. Shankar
Ashish P. Wasnik
Mahmoud M. Al-Hawary
Isaac R. Francis
Ravi K. Kaza
Publication date: 01-04-2018
Publisher: Springer US
Published in: Abdominal Radiology / Issue 4/2018
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-017-1363-5

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2018

Machine learning for medical ultrasound: status, methods, and future opportunities

Contrast-enhanced ultrasound of the liver: technical and lexicon recommendations from the ACR CEUS LI-RADS working group

Artifacts in contrast-enhanced ultrasound: a pictorial essay

How to set up a contrast-enhanced ultrasound service

Applications of contrast-enhanced ultrasound in the kidney

Contrast-enhanced ultrasound of malignant liver lesions

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials